Top Markets
Coin of the day
Gamida Cell Ltd. Gamida Cell Ltd.

Gamida Cell Ltd.

GMDA
Peringkat dalam Saham #35164
Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated... Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated to pioneering cell therapies aimed at eradicating blood cancers and other severe hematological conditions. The company's leading investigational product, omidubicelโ€”a specialized cell therapyโ€”has successfully concluded its Phase III clinical evaluation for individuals afflicted with high-risk hematologic malignancies. Furthermore, it is currently undergoing Phase I/II trials for patients suffering from severe aplastic anemia. Another significant therapeutic candidate, GDA-201, an immunotherapy harnessing natural killer cells, is progressing through Phase I/II studies to address relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Beyond these, Gamida Cell is actively advancing a broader natural killer (NK) cell pipeline, which includes GDA-301, GDA-401, GDA-501, and GDA-601, with the ambition of treating both hematologic cancers and solid tumors. Founded in 1998, the company maintains its corporate headquarters in Jerusalem, Israel.
Harga Saham
$0.0327
Terakhir disinkronkan: 2025-06-17
Kapitalisasi Pasar
$4.34M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
IL
Perdagangan Gamida Cell Ltd. (GMDA)

Kategori

Riwayat harga saham Gamida Cell Ltd. (GMDA)
Harga penutupan tertinggi: $0.03 pada 2025-06-01

Harga penutupan terendah: $9.40 pada 2018-10-01
Riwayat harga saham Gamida Cell Ltd. dari 2018 hingga 2026
Performa harga saham tahunan
Tahun Performa
2025 117.76%
2024 -95.28%
2023 -75.22%
2022 -48.32%
2021 -71.87%
2020 84.95%
2019 -55.53%
2018 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE